title: Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta.
abstract: Previously, we demonstrated that recombinant Semliki Forest virus (SFV) vector rapidly and selectively transfers genes into cultured vascular smooth muscle cells (VSMC), leaving endothelial cells (EC) unaffected. From this, we hypothesized that recombinant SFV in vivo only transfers genes into the media of balloon-injured but not intact vessel, that gene expression in VSMC is fast, and that the specificity of SFV for VSMC is caused by specific binding sites. To address these hypotheses, we studied the time course of in vivo SFV-LacZ and Ad-LacZ expression in balloon-injured rat aorta. In addition, the fusion characteristics of fluorescent pyrene-labeled SFV were explored in cultured VSMC and EC. In intact aorta, no LacZ expression was found in the intima or media at 24 h. In contrast, in denuded aorta, LacZ expression was detected in as early as 12 h after incubation. LacZ expression was predominantly present in the media. Ad-LacZ expression started after 12 h, but was predominantly present in the adventitia. Ad-LacZ expression in the media started after 72 h. In vitro transfection with SFV showed that fusion was higher and, moreover, saturable in VSMC as compared with EC, indicating the presence of specific SFV binding sites on VSMC, but not EC. From this we conclude that in vivo selectivity of SFV in balloon-injured vessels is based on the removal of the endothelium, which results in accessibility of VSMC in the media that carry specific binding sites for the SFV vector.
authors.affiliation: Department of Clinical Pharmacology, Groningen University Institute for Drug Exploration (GUIDE), University of Groningen, The Netherlands.
authors.forename: A J M
authors.initials: AJ
authors.lastname: Roks
authors.forename: R H
authors.initials: RH
authors.lastname: Henning
authors.forename: H
authors.initials: H
authors.lastname: Buikema
authors.forename: Y M
authors.initials: YM
authors.lastname: Pinto
authors.forename: M J J
authors.initials: MJ
authors.lastname: Kraak
authors.forename: R A
authors.initials: RA
authors.lastname: Tio
authors.forename: D
authors.initials: D
authors.lastname: de Zeeuw
authors.forename: H J
authors.initials: HJ
authors.lastname: Haisma
authors.forename: J
authors.initials: J
authors.lastname: Wilschut
authors.forename: W H
authors.initials: WH
authors.lastname: van Gilst
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000800:Angioplasty, Balloon / Q000009:adverse effects; D000818:Animals; D001012:Aorta, Abdominal / Q000293:injuries*; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism; D015870:Gene Expression; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D007763:Lac Operon; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012672:Semliki forest virus / Q000235:genetics*